Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.
J Clin Invest
; 130(9): 5027, 2020 09 01.
Article
in En
| MEDLINE
| ID: mdl-32870163
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Clin Invest
Year:
2020
Document type:
Article
Country of publication:
Estados Unidos